Hey all, welcome back to the Real Life Pharmacology podcast. I'm your host, pharmacist, Eric Christensen,

and I thank you so much for listening today. Go check out our free PDF. It is a top 200 study guide

at real life pharmacology.com. I get that simply for subscribing. So again, definitely go check

that out absolutely free to you. Great little review

if you're out in practice or if you're gearing up for any board exams in pharmacy school,

nursing school, med school, so on and so forth. So go take advantage of that free resource.

All right, so let's get into the drug of the day today, and that is eumacledinium.

Brand name of this medication is Incruz, Ellipta.

And the first point I wanted to make is I have seen people goof up with Elypta.

So Elypta is actually part of the brand name,

but it is actually refers to the device or the inhaler delivery system that the medication

utilizes. So there's lots of different drugs with the ending ellipta.

So when you go talk to somebody and say, hey, they're taking ellipta, well, that could mean a bunch of

different drugs potentially. And it's just referring to that inhaler delivery system.

Whereas in Cruz is more specific as far as the brand

name goes to the generic name of umacladinium.

All right, so this drug is a long-acting anti-muscarinic agent, also referred to as L-A-Rama therapy, so L-A-M-A.

And this is primarily going to be used in COPD. So how does this medication work?

Well, it blocks acetylcholine's action at muscarinic type 3 receptors.

And by blocking acetylcholine to action,

it's going to ultimately cause smooth muscle relaxation,

specifically bronchial, smooth muscle relaxation,

...